Table 1.
Characteristics of narcolepsy type 1 patients
| SXB | Modafinil | p‐value | |
|---|---|---|---|
| N | 59 | 22 | |
| Age (years) | 34.5 ± 13.4 | 39.0 ± 19.7 | .332 |
| Male (%) | 38 (64%) | 6 (27%) | .005 |
| Baseline BMI (kg/m2) | 28.6 ± 4.3 | 26.5 ± 5.5 | .070 |
| Follow‐up (years) | 2.0 ± 1.7 | 1.2 ± 1.2 | .054a |
| Male | 1.9 ± 1.5 | 0.9 ± 0.7 | .152a |
| Female | 2.2 ± 1.9 | 1.3 ± 1.4 | .134a |
| HLA‐DQB1*06:02 + | 56/57 | 18/19 | .408 |
| Hypocretin < 110 pg/ml | 32/35 | 6/7 | .638 |
Data indicate mean ± standard deviation.
BMI, body mass index; SXB, sodium oxybate.
p‐values result from Student's t tests for the difference between treatment groups.
a
To adjust for multiple testing, p‐values <.05/4 were considered to be significant.